Ok good response! I’m hearing you Fingers crossed something happens sooner rather than later Either way I’m a LT holder and am confident in the product being successful and management being able to deliver
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling